Details of the Drug

General Information of Drug (ID: DMHUQWN)

• Drug Name: Benzaldehyde O-4-butoxyphenylcarbamoyl oxime
• Synonyms: CHEMBL598243; benzaldehyde O-4-butoxyphenylcarbamoyl oxime

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

• Drug Type: Small molecular drug
• #Ro5 Violations (Lipinski): 0:
  Molecular Weight (mw); 312.4
  Logarithm of the Partition Coefficient (xlogp); 4.4
  Rotatable Bond Count (rotbonds); 8
  Hydrogen Bond Donor Count (hbonddonor); 1
  Hydrogen Bond Acceptor Count (hbondacc); 4
• Chemical Identifiers:
  Formula: C18H20N2O3
  IUPAC Name: [(E)-benzylideneamino] N-(4-butoxyphenyl)carbamate
  Canonical SMILES: CCCCOC1=CC=C(C=C1)NC(=O)O/N=C/C2=CC=CC=C2
  InChI: InChI=1S/C18H20N2O3/c1-2-3-13-22-17-11-9-16(10-12-17)20-18(21)23-19-14-15-7-5-4-6-8-15/h4-12,14H,2-3,13H2,1H3,(H,20,21)/b19-14+
  InChIKey: BRPRTDQSLVFYMR-XMHGGMMESA-N
• Cross-matching ID:
  PubChem CID: 20872791
  TTD ID: D0MR1Z

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Fatty acid amide hydrolase (FAAH)	TTDP1UC	NOUNIPROTAC	Inhibitor	[1]

Molecular Expression Atlas of This Drug

• The Studied Disease: Discovery agent
• ICD Disease Classification: N.A.

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Fatty acid amide hydrolase (FAAH)	DTT	NO-GeName	2.65E-01	0.02	0.1

References

• [1] Oxime carbamate--discovery of a series of novel FAAH inhibitors. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1272-7.